paricalcitol
CRE-2007.409-T
Phase 3 small_molecule terminated
Quick answer
paricalcitol for IgA Nephropathy is a Phase 3 program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chinese University of Hong Kong
- Indication
- IgA Nephropathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated